108 related articles for article (PubMed ID: 17064988)
21. Effect of obesity-related plasma hemodilution on serum tumor marker concentration in women.
Park M; Chang IH; Kang H; Han SS
J Obstet Gynaecol Res; 2015 May; 41(5):784-9. PubMed ID: 25421332
[TBL] [Abstract][Full Text] [Related]
22. Acquired renal cystic disease and tumor markers in chronic hemodialysis patients.
Polenakovic M; Sikole A; Dzikova S; Polenakovic B; Gelev S
Int J Artif Organs; 1997 Feb; 20(2):96-100. PubMed ID: 9093887
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
[TBL] [Abstract][Full Text] [Related]
24. Prediagnostic levels of carcinoembryonic antigen and CA 242 in colorectal cancer: a matched case-control study.
Palmqvist R; Engarås B; Lindmark G; Hallmans G; Tavelin B; Nilsson O; Hammarström S; Hafström L
Dis Colon Rectum; 2003 Nov; 46(11):1538-44. PubMed ID: 14605576
[TBL] [Abstract][Full Text] [Related]
25. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I
Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
[TBL] [Abstract][Full Text] [Related]
26. Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
Tsai CY; Liu KH; Chiu CT; Hsueh SW; Hung CY; Hsu JT; Tsang NM; Hung YS; Chou WC
Anticancer Res; 2021 May; 41(5):2711-2718. PubMed ID: 33952502
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma.
Marrelli D; Roviello F; De Stefano A; Farnetani M; Garosi L; Messano A; Pinto E
Oncology; 1999 Jul; 57(1):55-62. PubMed ID: 10394126
[TBL] [Abstract][Full Text] [Related]
28. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F
Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
Wang YR; Yan JX; Wang LN
J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study.
Turgutalp K; Ozhan O; Helvacı I; Ata A; Arican A; Boztepe B; Kıykım A
Clin Chem Lab Med; 2013 Apr; 51(4):889-95. PubMed ID: 23314541
[TBL] [Abstract][Full Text] [Related]
32. Carbohydrate Antigen 19-9 Increases the Predictive Efficiency of α-Fetoprotein for Prognosis of Resected Hepatocellular Carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Am Surg; 2018 Jan; 84(1):80-85. PubMed ID: 29428032
[TBL] [Abstract][Full Text] [Related]
33. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
[TBL] [Abstract][Full Text] [Related]
34. The characteristics of the serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer cases.
Wada N; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Surg Today; 2017 Feb; 47(2):227-232. PubMed ID: 27566604
[TBL] [Abstract][Full Text] [Related]
35. Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma.
Vukobrat-Bijedic Z; Husic-Selimovic A; Sofic A; Bijedic N; Bjelogrlic I; Gogov B; Mehmedovic A
Med Arch; 2013 Dec; 67(6):397-401. PubMed ID: 25568506
[TBL] [Abstract][Full Text] [Related]
36. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
Ozkan H; Kaya M; Cengiz A
Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
[TBL] [Abstract][Full Text] [Related]
37. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
Ahmadi H; Djaladat H; Cai J; Miranda G; Daneshmand S
Urol Oncol; 2014 Jul; 32(5):648-56. PubMed ID: 24680660
[TBL] [Abstract][Full Text] [Related]
38. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory.
Hui L; Rixv L; Xiuying Z
Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289
[TBL] [Abstract][Full Text] [Related]
39. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
40. Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection.
Liu X; Qiu H; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z; Sun X
Oncotarget; 2016 Jun; 7(23):35446-53. PubMed ID: 27147574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
